{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:35:59Z","timestamp":1720676159479},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.lpm.2006.08.001","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T05:23:55Z","timestamp":1201325035000},"page":"225-234","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P1","title":["Doit-on prescrire une\u00a0prophylaxie de\u00a0la\u00a0maladie thromboembolique aux\u00a0patients porteurs d'un cath\u00e9ter central et\/ou\u00a0recevant unechimioth\u00e9rapie pour\u00a0une\u00a0tumeur solide?"],"prefix":"10.1016","volume":"36","author":[{"given":"\u00c9ric","family":"Voog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Lazard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Juhel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2006.08.001_bib1","series-title":"Phlegmasia alba dolens. Clinique M\u00e9dicale de l\u2019H\u00f4tel Dieu de Paris","first-page":"695","author":"Trousseau","year":"1868"},{"key":"10.1016\/j.lpm.2006.08.001_bib2","first-page":"147","article-title":"The prethrombotic state in cancer","volume":"17","author":"Luzzatto","year":"1990","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0889-8588(05)70349-X","article-title":"Hypercoagulability in cancer","volume":"10","author":"Green","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.lpm.2006.08.001_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00325481.1993.11701721","article-title":"Thrombosis in patients with cancer","volume":"93","author":"Dhami","year":"1999","journal-title":"Postgrad Med"},{"key":"10.1016\/j.lpm.2006.08.001_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1613051","article-title":"Venous thrombosis in patients with solid tumors: determination of frequency and characteristics","volume":"87","author":"Sallah","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2006.08.001_bib6","first-page":"677","article-title":"Venous thrombosis during multinodal treatment of primary breast carcinoma","volume":"65","author":"Weiss","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.lpm.2006.08.001_bib7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/1097-0142(19841001)54:7<1264::AID-CNCR2820540706>3.0.CO;2-R","article-title":"Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients","volume":"54","author":"Goodnough","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.lpm.2006.08.001_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9343(89)80604-7","article-title":"Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study","volume":"87","author":"Wall","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2006.08.001_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.1991.9.2.286","article-title":"Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer","volume":"9","author":"Saphner","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib10","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1200\/JCO.1996.14.9.2560","article-title":"Blood coagulation during adjuvant epirubicin\/cyclophophamide chemotherapy in patients with primary operable breast cancer","volume":"14","author":"Von Tempelhoff","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib11","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1200\/JCO.2000.18.10.2169","article-title":"Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature","volume":"18","author":"Weijl","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1056\/NEJM198802183180703","article-title":"The thrombogenic effect of anticancer drugs therapy in women with stage II breast cancer","volume":"318","author":"Levine","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2006.08.001_bib13","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1200\/JCO.1996.14.10.2731","article-title":"Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer","volume":"14","author":"Pritchard","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1200\/JCO.1994.12.6.1266","article-title":"Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study","volume":"12","author":"Clahsen","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1055\/s-0038-1650276","article-title":"Thrombosis in cancer patients treated with hematopoietic growth factor a meta-analysis","volume":"75","author":"Barbui","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2006.08.001_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jpainsymman.2003.06.010","article-title":"The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events","volume":"27","author":"Rosenzweig","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.lpm.2006.08.001_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jnci\/dji087","article-title":"Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis","volume":"97","author":"Bohlius","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lpm.2006.08.001_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMra011883","article-title":"Preventing complications of central venous catheterization","volume":"348","author":"McGee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2006.08.001_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0720-048X(95)00633-2","article-title":"Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: a phlebographic study","volume":"20","author":"Balesteri","year":"1995","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.lpm.2006.08.001_bib20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1055\/s-0038-1648912","article-title":"Pulmonary embolism in patients with upper extremity DVT associated to venous central lines. A prospective study","volume":"72","author":"Monreal","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2006.08.001_bib21","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1200\/JCO.1996.14.9.2560","article-title":"Blood coagulation during adjuvant epirubicin\/cyclophophamide chemotherapy in patients with primary operable breast cancer","volume":"14","author":"Von Tempelhoff","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib22","first-page":"421","article-title":"The role of catheter composition in the development of thrombophlebitis","volume":"138","author":"Welch","year":"1974","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.lpm.2006.08.001_bib23","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1992.10.12.1943","article-title":"A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients","volume":"10","author":"Mueller","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1985.3.5.710","article-title":"Complications and management of implanted venous access catheters","volume":"5","author":"Lokich","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib25","first-page":"515","article-title":"The fate of 100 prolonged venous access devices","volume":"56","author":"Hayward","year":"1990","journal-title":"Am Surg"},{"key":"10.1016\/j.lpm.2006.08.001_bib26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1148\/radiol.2203001181","article-title":"Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US","volume":"3","author":"Luciani","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.lpm.2006.08.001_bib27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/1097-0142(19900901)66:5<900::AID-CNCR2820660515>3.0.CO;2-A","article-title":"Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation","volume":"66","author":"Haire","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.lpm.2006.08.001_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2257.1999.00250.x","article-title":"Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease","volume":"21","author":"Ratcliffe","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.lpm.2006.08.001_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial","volume":"112","author":"Bern","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2006.08.001_bib30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2141.1998.00732.x","article-title":"Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies","volume":"101","author":"Boraks","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2006.08.001_bib31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1445-5994.2002.00171.x","article-title":"Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis","volume":"32","author":"Heaton","year":"2002","journal-title":"Intern Med J"},{"key":"10.1016\/j.lpm.2006.08.001_bib32","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1200\/JCO.2005.10.192","article-title":"Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer","volume":"23","author":"Couban","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib33","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2000.18.21.3665","article-title":"Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors","volume":"18","author":"Carr","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/JCO.2003.02.042","article-title":"Minidose Warfarin Prophylaxis for Catheter-Associated Thrombosis in Cancer Patients: Can It Be Safely Associated With Fluorouracil-Based Chemotherapy?","volume":"21","author":"Masci","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line related thrombotic complications in children: The PROTEKT study","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.lpm.2006.08.001_bib36","first-page":"369a","volume":"21","author":"Reichardt","year":"2002","journal-title":"Proc Am Soc Clin Oncol."},{"key":"10.1016\/j.lpm.2006.08.001_bib37","first-page":"784a","article-title":"Dalteparin is effective as prophylaxis of central venous catheter-remated thrombosis in cancer patients","volume":"22","author":"Iniesta","year":"2003","journal-title":"Proc Am Soc Clin Oncol."},{"key":"10.1016\/j.lpm.2006.08.001_bib38","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","article-title":"Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients","volume":"23","author":"Verso","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib39","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(94)90008-6","article-title":"Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer","volume":"343","author":"Levine","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2006.08.001_bib40","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1200\/JCO.1989.7.7.879","article-title":"six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer","volume":"7","author":"Taylor","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198902233200803","article-title":"Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study","volume":"320","author":"Mansour","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2006.08.001_bib42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM198902233200804","article-title":"Ludwig Breast Cancer Study Group. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer","volume":"320","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2006.08.001_bib43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1200\/JCO.1990.8.6.1005","article-title":"Post-operative chemotherapy and tamoxifen compared with tamoxifene alone in the treatment of positive node breast cancer patients aged 50 years and older with tumours responsive to tamoxifen: results from the NSABP B16","volume":"8","author":"Fisher","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2006.08.001_bib44","first-page":"2078","article-title":"Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study","volume":"1","author":"Rivkin","year":"1994","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.lpm.2006.08.001_bib45","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/jnci\/89.22.1673","article-title":"Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer","volume":"89","author":"Fisher","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lpm.2006.08.001_bib46","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1200\/JCO.1999.17.7.1988","article-title":"Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group","volume":"17","author":"Wils","year":"1999","journal-title":"J Clin Oncol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498206000558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498206000558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T06:23:21Z","timestamp":1588314201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498206000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0755498206000558"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2006.08.001","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}